Literature DB >> 9384637

Bivariate frailty model for the analysis of multivariate survival time.

X Xue1, R Brookmeyer.   

Abstract

Because of limitations of the univariate frailty model in analysis of multivariate survival data, a bivariate frailty model is introduced for the analysis of bivariate survival data. This provides tremendous flexibility especially in allowing negative associations between subjects within the same cluster. The approach involves incorporating into the model two possibly correlated frailties for each cluster. The bivariate lognormal distribution is used as the frailty distribution. The model is then generalized to multivariate survival data with two distinguished groups and also to alternating process data. A modified EM algorithm is developed with no requirement of specification of the baseline hazards. The estimators are generalized maximum likelihood estimators with subject-specific interpretation. The model is applied to a mental health study on evaluation of health policy effects for inpatient psychiatric care.

Entities:  

Mesh:

Year:  1996        PMID: 9384637     DOI: 10.1007/bf00128978

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  3 in total

1.  Semiparametric estimation of random effects using the Cox model based on the EM algorithm.

Authors:  J P Klein
Journal:  Biometrics       Date:  1992-09       Impact factor: 2.571

2.  The relationship between wages and income and the timing and spacing of births: evidence from Swedish longitudinal data.

Authors:  J J Heckman; J R Walker
Journal:  Econometrica       Date:  1990-11       Impact factor: 5.844

3.  Managed mental health care and patterns of inpatient utilization for treatment of affective disorders.

Authors:  R G Frank; R Brookmeyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-08       Impact factor: 4.328

  3 in total
  14 in total

1.  Using frailties in the accelerated failure time model.

Authors:  W Pan
Journal:  Lifetime Data Anal       Date:  2001-03       Impact factor: 1.588

2.  What difference does the dependence between durations make? Insights for population studies of aging.

Authors:  A I Yashin; I A Iachine
Journal:  Lifetime Data Anal       Date:  1999       Impact factor: 1.588

3.  Dynamic random effects models for times between repeated events.

Authors:  D Y Fong; K F Lam; J F Lawless; Y W Lee
Journal:  Lifetime Data Anal       Date:  2001-12       Impact factor: 1.588

4.  Estimating marginal effects in accelerated failure time models for serial sojourn times among repeated events.

Authors:  Shu-Hui Chang
Journal:  Lifetime Data Anal       Date:  2004-06       Impact factor: 1.588

5.  Hierarchical likelihood inference on clustered competing risks data.

Authors:  Nicholas J Christian; Il Do Ha; Jong-Hyeon Jeong
Journal:  Stat Med       Date:  2015-08-16       Impact factor: 2.373

6.  A semiparametric transition model with latent traits for longitudinal multistate data.

Authors:  Haiqun Lin; Zhenchao Guo; Peter N Peduzzi; Thomas M Gill; Heather G Allore
Journal:  Biometrics       Date:  2008-03-19       Impact factor: 2.571

7.  Modeling two-state disease processes with random effects.

Authors:  E T Ng; R J Cook
Journal:  Lifetime Data Anal       Date:  1997       Impact factor: 1.588

8.  Semiparametric regression analysis for alternating recurrent event data.

Authors:  Chi Hyun Lee; Chiung-Yu Huang; Gongjun Xu; Xianghua Luo
Journal:  Stat Med       Date:  2017-11-23       Impact factor: 2.373

9.  Penalized survival models for the analysis of alternating recurrent event data.

Authors:  Lili Wang; Kevin He; Douglas E Schaubel
Journal:  Biometrics       Date:  2019-11-11       Impact factor: 2.571

10.  A joint frailty model provides for risk stratification of human immunodeficiency virus-infected patients based on unobserved heterogeneity.

Authors:  Tae Hyun Jung; Tassos Kyriakides; Mark Holodniy; Denise Esserman; Peter Peduzzi
Journal:  J Clin Epidemiol       Date:  2018-02-09       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.